RAM
FTXH icon

Riggs Asset Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Riggs Asset Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-114
Closed -$2K – 272
2017
Q3 		$2K Sell
114
-38
-25% -$766 ﹤0.01% 245
2017
Q2 		$3K Buy
+152
New +$3.06K ﹤0.01% 254

Other funds holding FTXH

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

Riggs Asset Management's FTXH Position: Q4 2017 in Review

Riggs Asset Management sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2017, closing a stake of 114 shares — an estimated $2K sold.

Riggs Asset Management first reported a position in FTXH in Q2 2017 and held it in 2 quarters. The position peaked at $3K in Q2 2017. 7 funds tracked by Wall St. Rank hold FTXH as of Q4 2017.

  • Riggs Asset Management reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • Riggs Asset Management sold 114 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2017, an estimated $2K.
  • Riggs Asset Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2017 and held it in 2 quarters.
  • Riggs Asset Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $3K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2017.

Based on Riggs Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.